Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone marrow transplantation correcting β‐galactosidase activity does not influence neurological outcome in juvenile GM1‐gangliosidosis

1 Sept 2005

Abstract excerpt

Donor bone marrow engraftment, which resulted in complete normalization of white cell beta-galactosidase levels in a patient with presymptomatic juvenile onset GM1-gangliosidosis (McKusick 230600), did not improve long-term clinical outcome.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Erythrocyte Function and Pathophysiology
Share to Lysosomal Storage Disorders Research
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16151914
DOI: 10.1007/s10545-005-0089-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Bone marrow transplantation correcting β‐galactosidase activity does not influence neurological outcome in juvenile GM1‐gangliosidosisPMID 16151914Read ↗

Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients.Semantic proximity Read ↗

GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.Semantic proximity Read ↗

Normal serum beta-galactosidase in juvenile GM1 gangliosidosis.Semantic proximity Read ↗

Genetics and Therapies for GM2 Gangliosidosis.Semantic proximity Read ↗

Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe DiseaseSemantic proximity Read ↗

Neurological manifestations of knockout mice with beta-galactosidase deficiency.Semantic proximity Read ↗

The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.Semantic proximity Read ↗

Central Nervous System-directed AAV2/5-Mediated Gene Therapy Synergizes with Bone Marrow Transplantation in the Murine Model of Globoid-cell LeukodystrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.